A finalist for the Idea Award, Zeaus developed Doctor Phage, a next-generation antibacterial therapy that combines stable bacteriophages with nanoparticles to overcome resistance, toxicity, and instability—outperforming antibiotics against deadly ESKAPE pathogens and paving the way for scalable, life-saving treatments.

‍